Home alone – depression highest for those living alone

 

London, UK (March 23, 2012) – The number of people living on their own has doubled, over the last three decades, to one in three in the UK and US. New research published in BioMed Central’s open access journal BMC Public Health shows that the risk of depression, measured by people taking antidepressants, is almost 80% higher for those living alone compared to people living in any kind of social or family group.

 

For women a third of this risk was attributable to sociodemographic factors, such as lack of education and low income. For men the biggest contributing factors included poor job climate, lack of support at the work place or in their private lives, and heavy drinking.

 

It is known that living alone can increase the risk of mental health problems for the elderly, and for single parents, but little is known about the effects of isolation on working-age people. Researchers in Finland followed 3500 working-aged men and women for seven years and compared their living arrangements with psychosocial, sociodemographic, and health risk factors, including smoking, heavy drinking and low physical activity, to antidepressant use. Information on antidepressant medication was taken from the National Prescription Register.

 

Dr Laura Pulkki-Råback, who conducted the research at the Finnish Institute of Occupational Health, explained, "Our study shows that people living alone have an increased risk of developing depression. Overall there was no difference in the increased risk of depression by living alone for either men or women. Poor housing conditions (especially for women) and a lack of social support (particularly for men) were the main contributory factors to this increased risk."

 

She continued, "This kind of study usually underestimates risk because the people who are at the most risk tend to be the people who are least likely to complete the follow up. We also were not able to judge how common untreated depression was."

 

While this study clearly identifies some of the factors which increase the risk of depression for people who live alone, over half the increase in risk is still unexplained. The researchers suggest that this may be due to feelings of alienation from society, lack of trust, or difficulties arising from critical life events. All these factors need to be addressed in order to begin understanding and reducing the incidence of depression amongst working age people.

 

 

Notes to Editors 

  1. Living alone and antidepressant medication use: a prospective study in a working-age population
    Laura Pulkki-Raback, Mika Kivimaki, Kirsi Ahola, Kaisla Joutsenniemi, Marko Elovainio, Helena Rossi, Sampsa Puttonen, Seppo Koskinen, Erkki Isometsa, Jouko Lonnqvist and Marianna Virtanen
    BMC Public Health (in press)
  2. BMC Public Health is an open access, peer-reviewed journal that considers articles on the epidemiology of disease and the understanding of all aspects of public health. The journal has a special focus on the social determinants of health, the environmental, behavioral, and occupational correlates of health and disease, and the impact of health policies, practices and interventions on the community.
  3. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector

 


 

BioMed Central (http://www.biomedcentral.com/), 23.03.2012 (tB).

MEDICAL NEWS

COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…
Suliqua®: In komplexem Umfeld – einfach besser eingestellt
Suliqua®: Überlegene HbA1c-Senkung  im Vergleich zu Mischinsulinanalogon
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 

ERNÄHRUNG

Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen

ONKOLOGIE

Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
WHO veröffentlicht erste Klassifikation von Tumoren im Kindesalter
Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!

MULTIPLE SKLEROSE

Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…
Stellungnahme zur 3. Impfung gegen SARS-CoV2 bei Personen mit MS
NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…